Ever forget the difference between an IND, a Phase I and Phase II trial? The difference between protein expression and gene expression profiling? The National Cancer Institute has a nifty tutorial that breaks down the development process of new, targeted therapies in cancer. It’s a good resource for anyone – be it you, a friend, a colleague, a […]
Tolero Pharmaceuticals, a Salt Lake City, Utah drug developer, has set its sights on ramping up the commercialization and development efforts of its acute myeloid leukemia treatment, which will enter Phase 3 trial sometime next year. The company’s fresh off of closing a Series B round of $14.2 million, though the initial aim for the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Jaron Lanier is a computer scientist who thinks that Facebook should pay users for their data. After all it’s the content from individual users that has enabled the company to become a billion-dollar business ($1.81 billion in Q2 2014). Without users posting comments and pictures and links, what does Facebook have? Nothing. How do users […]
Breaking out of research silos and collaborating more openly will be a big step in driving personalized medicine forward, said Dr. Andrew Futreal, a professor of genomic medicine at MD Anderson. Futreal was one of a dozen personal-medicine experts from the private, public and academic sectors who spoke at a Path2Cures hearing Wednesday in front of the House Energy […]
Personalized medicine is here. But it’s up to insurance carriers to catch up with technology that’s hurtling forward faster and faster, or so says Manuel Glynias, CEO of Cleveland-based GenomOncology, His company is in the business of solving how doctors can use genomic data to treat cancer, the first major frontier in the application of personalized medicine. It’s difficult to parse the […]
Personalized medicine will be expensive in these early days of pioneering and planning. But individual genomic testing is not going to be exorbitant forever – and the ROI is gonna be big, both in patient outcomes and dollars saved, said a panel of speakers at MedCity’s CONVERGE conference in Philadelphia. “Because pharmacogenomics is rooted in the pathobiology of disease, […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Dr. Amy Abernethy, a medical oncologist from Duke University School of Medicine who has championed clinical informatics and working with patients to develop more personalized cancer care, has joined Flatiron Health.
When it comes to genomic technology, Carol Isaacson Barash is a go-to source. She is the founder of Helix Health Advisors, a consultancy specializing in integrating transformative genomic technologies at the point of care. She also has 25 years of experience in genetics/genomics technologies, bioethics and applications to clinical care. Barash will be speaking at 9:20 a.m. […]
A team of doctors pressed for time used DNA testing to diagnose a rare bacterial infection in a 14-year-old boy with encephalitis. The case, written up in the New England Journal of Medicine and widely covered in media reports this week, represents what could one day become commonplace as medical innovations make it easier to […]
As pharmaceutical companies look for ways to add value to their drugs to solve problems like adherence, many see digital health as an important part of that strategy. Respiratory drug developer Opko Health (NYSE: OPK) has acquired an Israeli medical device startup, Inspiro Medical, with a digital dry powder inhaler under development, according to a […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
TV host Samantha Harris is the latest in a series of celebrities going public with her decision to have a double mastectomy following a breast cancer diagnosis. As the number of women choosing this treatment continues to rise, reporter and author Marc Silver wanted to present the other side of the discussion. His wife, Marsha, […]
“MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences” An Indiana life sciences company looks at metabolites as snapshots to diagnose and monitor cancer. The idea is that cancerous cells have distinct differences in metabolism than healthy cells. Matrix-Bio, a startup with corporate […]
The hypothetical choice like the one in our Elite Eight bracket between Artefact’s seizure tracking device and ZOLL Medical’s personal and portable defibrillator may not be the sort of thing that keeps people up at night. Maybe that’s because these are the sort of choices that are made every day. Which technology is more practical, […]
Retinitis pigmentosa is the most common inherited eye disease. Mutations in the gene for rhodopsin, the pigment for photoreceptor cells in the retina responsible for the perception of light, account for 15 percent of retinitis pigmentosa cases. CHOP spinout Spark Therapeutics, which has a late stage retinitis pigmentosa gene therapy treatment under development, is collaborating […]
Watson is turning into quite the oncology expert. In its latest healthcare technology news, the computer platform is being used as part of a collaboration between IBM and New York Genome Center. Glioblastomas, an aggressive, frequently malignant brain tumor that kills more than 13,000 people in the U.S. each year, will be the focus of […]